- What we do
- Medical careers & training
- CPD, education & revalidation
- My RCP
Revised statement - June 2011
The Royal College of Physicians originally agreed guidelines on The diagnosis and management of primary hypothyroidism in November 2008. These have now been formally re-endorsed. This follows a review, conducted in line with best practice policies, by the co-publishing organisations:
- The Royal College of Physicians, in particular its Patient and Carer Network and the Joint Specialty Committee for Endocrinology & Diabetes
- The Association for Clinical Biochemistry
- The Society for Endocrinology
- The British Thyroid Association
- The British Thyroid Foundation Patient Support Group
- The British Society of Paediatric Endocrinology and Diabetes
The outcome of the review was that the advice from 2008 to those treating hypothyroidism remains valid. Minor amendments have been made to give further explanation where thought applicable. This includes replacing mention of thyroxine (T4) tablets with levothyroxine tablets, a synthetic form of the thyroid hormone thyroxine (also abbreviated to T4).
Both the original 2008 statement and the revised guidelines in 2011 are available below.